XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
REVENUE        
Revenue $ 3,917,467   $ 6,904,163  
TOTAL REVENUE 3,917,467   6,904,163  
OPERATING EXPENSES        
Research and development 8,817,389 $ 4,965,088 16,478,908 $ 10,080,787
General and administrative 2,847,337 2,356,666 6,357,222 5,072,501
TOTAL OPERATING EXPENSES 11,664,726 7,321,754 22,836,130 15,153,288
LOSS FROM OPERATIONS (7,747,259) (7,321,754) (15,931,967) (15,153,288)
OTHER INCOME (EXPENSE)        
Other income   190,582   190,582
Investment income 380,680 21,761 797,122 35,201
TOTAL OTHER INCOME (EXPENSE) 380,680 212,343 797,122 225,783
NET LOSS (7,366,579) (7,109,411) (15,134,845) (14,927,505)
OTHER COMPREHENSIVE INCOME (LOSS)        
Net unrealized gain on marketable securities 84,707 22,830 74,449 22,830
COMPREHENSIVE LOSS $ (7,281,872) $ (7,086,581) $ (15,060,396) $ (14,904,675)
Net loss per share, basic $ (0.29) $ (0.29) $ (0.60) $ (0.61)
Net loss per share, diluted $ (0.29) $ (0.29) $ (0.60) $ (0.61)
Weighted-average number of shares of common stock outstanding basic 25,335,342 24,324,156 25,291,591 24,303,564
Weighted-average number of shares of common stock outstanding diluted 25,335,342 24,324,156 25,291,591 24,303,564